Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The use of FDG-PET to detect residual disease after induction chemotherapy and definite chemoradiotherapy for squamous cell cancer of the head and neck

McCollum AD, Van den Abbeele AD, Haddad RI, Burrell SC, Norris CM, Tishler RB, Case MA, Posner MR. The use of FDG-PET to detect residual disease after induction chemotherapy and definite chemoradiotherapy for squamous cell cancer of the head and neck. Sixth Research Workshop on the Biology, Prevention, and Treatment of Head and Neck Cancer. Virginia. 2000.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.